Human mesenchymal stem cells: A bank perspective on the isolation, characterization and potential of alternative sources for the regeneration of musculoskeletal tissues
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
The continuous discovery of human mesenchymal stem cells (hMSCs) in different tissues is stirring up a tremendous interest as a cell source for regenerative medicine therapies. Historically, hMSCs have been always considered a sub‐population of mononuclear cells present in the bone marrow (BM). Although BM‐hMSCs are still nowadays considered as the most promising mesenchymal stem cell population to reach the clinics due to their capacity to differentiate into multiple tissues, hMSCs derived from other adult and fetal tissues have also demonstrated to possess similar differentiation capacities. Furthermore, different reports have highlighted a higher recurrence of hMSCs in some of these tissues as compared to BM. This offer a fascinating panorama for cell banking, since the creation of a stem cell factory could be envisioned where hMSCs are stocked and used for ad hoc clinical applications. In this review, we summarize the main findings and state of the art in hMSCs isolation, characterization, and differentiation from alternative tissue sources and we attempt to compare their potency for musculoskeletal regeneration. J. Cell. Physiol. 228: 680–687, 2013. © 2012 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kern, S., Eichler, H., Stoeve, J., Klüter, H., & Bieback, K. (2006) · STEM CELLS · doi:10.1634/stemcells.2005-0342 · Cited by 3,370 · cited 1×
“Careful analysis of potential genetic modifications due to extensive cell culture and expansion should be also carried to evaluate tumorogenesis, replicative aging, and loss of differentiation potential risks (Sekiya et al., 2002; Stolzing and Scutt, 2006; Wagner et al., 2010; Klopp et al., 2011).”
BackgroundMesenchymal stem cells as trophic mediators
Caplan, A. I., & Dennis, J. E. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20886 · Cited by 2,992
Isolation of multipotent mesenchymal stem cells from umbilical cord blood
Lee, O. K., Kuo, T. K., Chen, W.-M., Lee, K.-D., Hsieh, S.-L., & Chen, T.-H. (2004) · Blood · doi:10.1182/blood-2003-05-1670 · Cited by 1,360
Klopp, A. H., Gupta, A., Spaeth, E., Andreeff, M., & Marini, F. (2011) · Stem Cells · doi:10.1002/stem.559 · Cited by 562 · cited 1×
“Careful analysis of potential genetic modifications due to extensive cell culture and expansion should be also carried to evaluate tumorogenesis, replicative aging, and loss of differentiation potential risks (Sekiya et al., 2002; Stolzing and Scutt, 2006; Wagner et al., 2010; Klopp et al., 2011).”
BackgroundEngineered Microenvironments for Controlled Stem Cell Differentiation
Burdick, J. A., & Vunjak-Novakovic, G. (2009) · Tissue Engineering Part A · doi:10.1089/ten.tea.2008.0131 · Cited by 485
Adult human mesenchymal stem cell as a target for neoplastic transformation
Serakinci, N., Guldberg, P., Burns, J. S., Abdallah, B., Schrødder, H., Jensen, T., & Kassem, M. (2004) · Oncogene · doi:10.1038/sj.onc.1207651 · Cited by 350 · cited 1×
“Placenta andWharton’s jelly derived hMSCs seem to be equally frequent, yet the protocols so far used for isolation are cumbersome and long (Seshareddy et al., 2008; Fariha et al., 2011).”
BackgroundNoël, D., Caton, D., Roche, S., Bony, C., Lehmann, S., Casteilla, L., Jorgensen, C., & Cousin, B. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.12.022 · Cited by 343
Das, R., Jahr, H., van Osch, G. J. V. M., & Farrell, E. (2010) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2009.0296 · Cited by 297 · cited 1×
“…low oxygen tensions typically results in enhanced lifespan and differentiation capacities of hMSCs (Fehrer et al., 2007; Markway et al., 2010), a drastic change in these levels could potentially result in the production of harmful reactive oxygen species (Potier et al., 2007; Das et al., 2010).”
Background
Cited by
Targeting the tumour stroma to improve cancer therapy
Valkenburg, K. C., de Groot, A. E., & Pienta, K. J. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0007-1 · Cited by 1,084
Mesenchymal stem cells: mechanisms and role in bone regeneration
Qin, Y., Guan, J., & Zhang, C. (2014) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2013-132387 · Cited by 122
Nicolay, N. H., Perez, R. L., Rühle, A., Trinh, T., Sisombath, S., Weber, K.-J., Ho, A. D., Debus, J., Saffrich, R., & Huber, P. E. (2016) · Scientific Reports · doi:10.1038/srep20035 · Cited by 41
Production and quality testing of multipotent mesenchymal stromal cell therapeutics for clinical use
Bieback, K., Kuçi, S., & Schäfer, R. (2019) · Transfusion · doi:10.1111/trf.15252 · Cited by 24
Metadata
- Authors
- Moroni, L., & Fornasari, P. M.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 2012-12-20
- Volume
- 228
- Issue
- 4
- Pages
- 680-687
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W2133368655
- Cited by
- 79
- References
- 8
- FWCI
- 3.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.